ABBV AbbVie Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

ABBV [NYSE]

AbbVie Inc.

Healthcare | Drug Manufacturers - General | USA

statements

Index	S&P 500	P/E	16.50	EPS (ttm)	5.65	Insider Own	0.10%	Shs Outstand	1.48B	Perf Week	-3.88%
Market Cap	166.29B	Forward P/E	7.85	EPS next Y	11.88	Insider Trans	-4.76%	Shs Float	1.47B	Perf Month	-6.14%
Income	8.39B	PEG	1.38	EPS next Q	2.75	Inst Own	64.00%	Short Float	0.93%	Perf Quarter	9.17%
Sales	34.06B	P/S	4.88	EPS this Y	42.30%	Inst Trans	1.63%	Short Ratio	1.48	Perf Half Y	7.64%
Book/sh	-5.01	P/B	-	EPS next Y	15.10%	ROA	10.60%	Target Price	104.69	Perf Year	43.97%
Cash/sh	-	P/C	-	EPS next 5Y	11.93%	ROE	-96.80%	52W Range	62.55 - 101.28	Perf YTD	5.32%
Dividend	4.72	P/FCF	25.96	EPS past 5Y	36.80%	ROI	21.20%	52W High	-8.79%	Beta	0.80
Dividend %	5.06%	Quick Ratio	3.00	Sales past 5Y	10.80%	Gross Margin	77.10%	52W Low	47.69%	ATR	1.98
Employees	30000	Current Ratio	3.10	Sales Q/Q	10.10%	Oper. Margin	38.10%	RSI (14)	32.97	Volatility	2.29% 2.01%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	22.50%	Profit Margin	23.00%	Rel Volume	0.77	Prev Close	93.25
Shortable	Yes	LT Debt/Eq	-	Earnings	Jul 31 BMO	Payout	80.90%	Avg Volume	9.27M	Price	92.38
Recom	1.90	SMA20	-5.14%	SMA50	-3.84%	SMA200	5.30%	Volume	3,156,288	Change	-0.93%

Jun-23-20

Upgrade

Atlantic Equities

Neutral → Overweight

$115

Jun-09-20

Upgrade

Wolfe Research

Peer Perform → Outperform

Jun-02-20

Upgrade

Argus

Hold → Buy

$115

May-18-20

Resumed

BofA/Merrill

Neutral

$95

May-12-20

Upgrade

JP Morgan

Neutral → Overweight

$105

May-11-20

Resumed

Morgan Stanley

Overweight

$95

Apr-20-20

Upgrade

RBC Capital Mkts

Sector Perform → Outperform

$79 → $93

Mar-23-20

Downgrade

Societe Generale

Buy → Hold

Feb-27-20

Initiated

Barclays

Equal Weight

$97

Feb-06-20

Initiated

Mizuho

Buy

Jan-07-20

Initiated

RBC Capital Mkts

Sector Perform

$86

Dec-26-19

Reiterated

Cowen

Outperform

$90 → $98

Sep-26-19

Upgrade

Citigroup

Neutral → Buy

$87 → $90

Aug-20-19

Upgrade

Piper Jaffray

Neutral → Overweight

$80

Jun-27-19

Upgrade

Wolfe Research

Underperform → Peer Perform

Jun-26-19

Upgrade

SVB Leerink

Mkt Perform → Outperform

$88

May-28-19

Initiated

Goldman

Neutral

Apr-29-19

Upgrade

BMO Capital Markets

Underperform → Market Perform

Mar-25-19

Downgrade

Argus

Buy → Hold

Jan-23-19

Initiated

UBS

Neutral

$91

Aug-04-20 07:44PM	3 Diverse Large-Cap Stocks to Buy Now to Boost Your Long-Term Portfolio Zacks
06:34AM	How Neurocrine Biosciences Crushed It in Q2 Motley Fool
Aug-03-20 07:56AM	AbbVie, Amgen and Takeda start testing drugs as COVID-19 treatments MarketWatch
07:30AM	Members Of The COVID R&D Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial PR Newswire
07:29AM	AbbVie Inc.'s (NYSE:ABBV) P/E Is On The Mark Simply Wall St.
07:00AM	A Giant Pension Sold Apple and Intel Stock. Here Are Two Stocks It Bought. Barrons.com
Aug-02-20 04:31PM	The Market Continues to Undervalue AbbVie GuruFocus.com
09:07AM	2 Stocks to Supplement Your Social Security Income Motley Fool
Jul-31-20 08:32PM	AbbVie (ABBV) Q2 2020 Earnings Call Transcript Motley Fool
04:33PM	AbbVie Earnings Top, Drug Giant Rebounds Bullishly, Flashes Buy Signal Investor's Business Daily
01:09PM	AbbVie's (ABBV) Q2 Earnings and Revenues Beat Estimates Zacks
12:44PM	Pharma Stock Roundup: Q2 Earnings & J&J and PFE's Coronavirus Updates in Focus Zacks
11:54AM	5 Key Things You'll Want to Know About AbbVie's Q2 Update Motley Fool
10:31AM	Let's Not Overlook AbbVie's Q2 Beat TheStreet.com
10:26AM	AbbVie Beats Earnings Expectations but Stock Falls Anyway Barrons.com
10:19AM	Earnings & Economic Data Deluge Zacks
09:47AM	AbbVie Shares Climb After Adjusted Profit Beats Analyst Views TheStreet.com
09:05AM	AbbVie (ABBV) Q2 Earnings and Revenues Beat Estimates Zacks
08:14AM	AbbVie shares rises on strong Q2, though cosmetic Botox sales tumbled 43% MarketWatch
07:54AM	AbbVie's Humira powers profit beat as COVID-19 weighs on Botox sales Reuters
Jul-30-20 01:06PM	A Preview Of AbbVie's Earnings Benzinga
09:38AM	Why Earnings Season Could Be Great for AbbVie (ABBV) Zacks
Jul-29-20 11:45AM	Why AbbVie (ABBV) is a Great Dividend Stock Right Now Zacks
08:45AM	AbbVie Announces Positive Phase 3 Data for Atogepant in Migraine Prevention PR Newswire
Jul-28-20 05:35PM	Novo, Roche Scored Highest Returns on Invested Capital GuruFocus.com
12:10PM	Why the Earnings Surprise Streak Could Continue for AbbVie (ABBV) Zacks
11:42AM	Will Humira, Cancer Drugs Drive AbbVie (ABBV) Q2 Earnings? Zacks
08:45AM	Third Pivotal Phase 3 Study Shows RINVOQ (upadacitinib) Plus Topical Corticosteroids Improves Skin and Itch Symptoms in Atopic Dermatitis Patients PR Newswire
07:00AM	We can eliminate Hepatitis C in Canada by 2030 CNW Group
Jul-27-20 12:05PM	What Lies Ahead for Healthcare ETFs in Q2 Earnings? Zacks
11:30AM	Has AbbVie (ABBV) Outpaced Other Medical Stocks This Year? Zacks
10:30AM	How Damaging Will Coronavirus be for AbbVie (ABBV) Q2 Earnings? Zacks
08:00AM	AbbVie Joins The Coronavirus Drug Hunt Is AbbVie Stock A Buy? Investor's Business Daily
Jul-26-20 06:48AM	3 Coronavirus Stocks With the Highest Dividend Yields Motley Fool
Jul-25-20 08:35AM	2 Market-Beating Dividend Stocks With Above-Average Payouts Motley Fool
07:03AM	Could Editas Medicine Be a Millionaire-Maker Stock? Motley Fool
Jul-24-20 08:07PM	Even as Indy Goes Autonomous, the Race to True Self-Driving Has Been Long Barrons.com
06:11PM	AbbVie Proves Masterful at Playing Drug Patent Game GuruFocus.com
04:57PM	Trump signs executive order aimed at lowering drug prices Yahoo Finance Video
02:06PM	5 High-Yield Drug Stocks That Are Undervalued With Great Upside InvestorPlace
12:30PM	Analysts Estimate AbbVie (ABBV) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-23-20 06:07PM	3 Strong Dividend Stocks to Buy Now for Income & Coronavirus Growth Zacks
Jul-22-20 10:16AM	AbbVie's Rinvoq Meets Late-Stage Eczema Study Endpoints Zacks
06:42AM	Is AbbVie a Great Dividend Stock? Motley Fool
Jul-21-20 08:45AM	RINVOQ (upadacitinib) Monotherapy Meets All Primary and Secondary Endpoints in Second Phase 3 Study for Atopic Dermatitis PR Newswire
08:07AM	2 High-Yield Dividend Stocks I'd Buy Right Now Motley Fool
Jul-20-20 09:15AM	AbbVie (ABBV) Hits 52-Week High, Can the Run Continue? Zacks
08:13AM	Thematic Investing Makes Way Through the Pandemic: 5 Picks Zacks
05:31AM	Allergan Withdraws EU, Japan Filing For Macular Degeneration Drug SmarterAnalyst
Jul-19-20 06:45AM	3 Fantastic Dividend Stocks to Buy When the Market Crashes Again Motley Fool
Jul-17-20 10:24AM	J&J Sets in Motion Pharma Q2 Earnings: 3 Stocks to Buy Zacks
06:43AM	These 3 Stocks Are Still Ridiculously Cheap Right Now Motley Fool
Jul-16-20 06:22PM	Pharmas Seeking to Overcome Patent Expirations GuruFocus.com
11:50AM	Should Value Investors Buy AbbVie (ABBV) Stock? Zacks
Jul-15-20 08:40AM	Researchers Say AbbVie's Tricor Reduced Severity Of COVID-19 Into 'Nothing Worse Than A Common Cold' Benzinga
Jul-14-20 06:42PM	New Products, Expanded Indications Drive Sales of Top 5 Pharmas GuruFocus.com
05:45PM	AbbVie (ABBV) Gains But Lags Market: What You Should Know Zacks
08:55AM	Do Options Traders Know Something About AbbVie (ABBV) Stock We Don't? Zacks
Jul-13-20 06:33PM	Roche Forecasted to Be Top Drug Seller in 2026 GuruFocus.com
11:45AM	Why AbbVie (ABBV) is a Great Dividend Stock Right Now Zacks
Jul-10-20 01:07PM	AbbVie (ABBV) Gets FDA Nod for Another Botox Label Expansion Zacks
09:31AM	Top Ranked Income Stocks to Buy for July 10th Zacks
07:25AM	The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs Benzinga
Jul-09-20 06:32PM	FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity PR Newswire
Jul-08-20 11:30AM	Is AbbVie (ABBV) Stock Outpacing Its Medical Peers This Year? Zacks
08:11AM	6 Stocks to Wade Through the Spike in Coronavirus Cases Zacks
07:27AM	Better Buy: AbbVie vs. Biogen Motley Fool
Jul-07-20 03:42PM	The March to Freedom Fund 2nd-Quarter Review GuruFocus.com
11:40AM	5 Companies Reach 52-Week Highs GuruFocus.com
10:13AM	Top Ranked Value Stocks to Buy for July 7th Zacks
08:53AM	4 Value Stocks to Buy in a Recovering Economy Zacks
08:00AM	AbbVie to Host Second-Quarter 2020 Earnings Conference Call PR Newswire
06:41AM	3 Best-Performing Dividend Aristocrats in the First Half of 2020: Are They Buys Now? Motley Fool
06:33AM	Shareholders Of AbbVie (NYSE:ABBV) Must Be Happy With Their 75% Return Simply Wall St.
Jul-06-20 09:59AM	4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger Zacks
Jul-05-20 07:04AM	Got $5,000? Buy These 3 High-Yield Dividend Stocks That Are Money Machines Motley Fool
Jul-03-20 09:15AM	AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run? Zacks
08:07AM	Better Coronavirus Stock: Eli Lilly or AbbVie? Motley Fool
07:00AM	5 High-Yield Dividend Stocks to Watch Motley Fool
Jul-02-20 05:35PM	Were Hedge Funds Right About Piling Into AbbVie Inc (ABBV)? Insider Monkey
12:32PM	AbbVie Is Cheap and Pays an Attractive Yield InvestorPlace
08:37AM	Top Ranked Income Stocks to Buy for July 2nd Zacks
Jul-01-20 02:08PM	Buy Pharma Giant AbbVie Stock for Growth, Income & Coronavirus Safety Zacks
12:00PM	What Makes AbbVie (ABBV) a New Strong Buy Stock Zacks
09:33AM	Zacks.com featured highlights include: Kroger, AbbVie, W.W. Grainger, West Pharmaceutical Services and Taiwan Semiconductor Manufacturing Company Zacks
09:29AM	Ollie's Bargain Outlet, Designer Brands, AbbVie, Microsoft and Lockheed Martin highlighted as Zacks Bull and Bear of the Day Zacks
Jun-30-20 02:35PM	3 Dividend Stocks to Buy for Second Half of 2020 for Coronavirus Safety Zacks
12:12PM	Top Marijuana Stocks That Pay Dividends Investopedia
09:52AM	Signs That Your Trading Will Ruin Your Retirement - June 30, 2020 Zacks
Jun-29-20 08:05AM	Wall Street Braces for Higher Bouts of Volatility: 5 Safe Picks Zacks
Jun-26-20 11:45AM	Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio Zacks
08:28AM	The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts Benzinga
08:25AM	AbbVie's Eye Disorder Candidate Gets Complete Response Letter Zacks
08:21AM	How gene therapy and CRISPR are helping to cure blindness MarketWatch
01:15AM	Allergan, an AbbVie Company, and Molecular Partners Receive Complete Response Letter from FDA on Biologics License Application for Abicipar pegol PR Newswire
Jun-25-20 12:17PM	The Zacks Analyst Blog Highlights: LLY, ABBV, NBIX and RDY Zacks
09:00AM	Alector Announces Publication of Preclinical and Phase 1 Data Validating Potential of AL002, a TREM2 Activating Antibody for the Treatment of Alzheimers Disease, in The Journal of Experimental Medicine GlobeNewswire
03:41AM	Sosei, AbbVie sign drug discovery deal worth up to $1 billion Reuters
Jun-24-20 01:43PM	Here are the factors, and the stocks, that will help you play the COVID-19 market MarketWatch
11:05AM	Appeals Court Rules Against J&J but Cuts Talc- Powder Verdict Zacks

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ALBAN CARLOS	Vice Chairman	Jul 07	Sale	100.00	53,325	5,332,555	114,899	Jul 08 09:19 PM
Stewart Jeffrey Ryan	SVP, US Commercial Operations	May 12	Sale	90.00	23,024	2,072,211	52,760	May 12 05:44 PM
RICHMOND TIMOTHY J.	EVP, Chief HR Officer	May 05	Sale	85.00	19,445	1,652,825	0	May 07 05:01 PM
Durkin Brian L	VP, Controller	Mar 30	Buy	69.00	750	51,750	16,844	Mar 20 04:56 PM
Durkin Brian L	VP, Controller	Mar 20	Buy	67.50	800	54,000	16,094	Mar 20 04:56 PM
Durkin Brian L	VP, Controller	Mar 18	Buy	68.18	2,200	150,005	15,294	Mar 20 04:56 PM
RAPP EDWARD J	Director	Mar 03	Buy	87.87	2,875	252,617	2,875	Mar 04 05:14 PM
RICHMOND TIMOTHY J.	EVP, Chief HR Officer	Sep 27	Sale	75.02	15,515	1,163,873	0	Oct 01 05:52 PM
Schumacher Laura J	Vice Chairman	Sep 16	Buy	70.42	25,000	1,760,523	164,838	Sep 18 04:25 PM
Donoghoe Nicholas	SVP, Enterprise Innovation	Aug 29	Buy	66.19	7,525	498,057	13,090	Aug 30 04:08 PM
Stewart Jeffrey Ryan	SVP, US Commercial Operations	Aug 16	Buy	64.44	15,552	1,002,169	65,304	Aug 20 04:16 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience